Friday, August 2, 2013to Sunday, August 4, 2013
The annual mixed doubles tournament, sponsored by Storm Bowling Products and the Professional Bowlers Association, benefits the CHRISTUS Stehlin Foundation and plays host to many of the world’s greatest male and female bowlers.
The tournament is one of the most prestigious doubles events in America. It’s expected to fill up early, so download your Entry Form today!
The Pro-Am portion of the tournament is your chance to bowl with the pros. There are separate divisions for Youth, Seniors and Adults. Pro-Am spots are available for Friday, August 2nd at 6pm and Saturday, August 3rd at 8pm. Download a Pro-Am Entry Form.
Contact Donna Conners (deeconn [at] inorbit [dot] com / 281-924-3085) with questions on this great event. Or refer to the Tournament web page for more information. Come bowl with the best and make some Strikes Against Breast Cancer!
November 23, 2013
Since its founding in 1997, Golfers Against Cancer has had one goal: to fund cancer research. Virtually all the money raised in GAC tournaments and events goes directly to cancer research organizations, including the CHRISTUS Stehlin Foundation.
August 2, 2013
The 14th Annual Luci Bonneau Memorial Striking Against Breast Cancer Mixed Doubles Bowling Tournament is one of the most prestigious doubles events in America. The tournament includes a Pro-Am - your chance to bowl with the pros to cure breast cancer!
October 19, 2013 | 7:00 p.m.
Get ready to disco and dance the night away at The Friends of CHRISTUS Stehlin Gala! Premiering “STAYIN’ ALIVE,” The Greatest Bee Gees Tribute Band with Members of the Houston Symphony Orchestra and America’s first Mash Up Group, “THE COMPANY MEN.”
May 4, 2013
On May 4th, 2013, young women will take the field for the first time in an exciting powder puff football game with teams comprised of some of best and brightest in Austin. The game is designed to bring the passion and spirit of young community leaders together to support Young Texans Against Cancer.
“Compared with other anticancer drugs at similar stages of development, camptothecins have demonstrated a much higher anticancer activity. Camptothecins can be envisioned as the ultimate anticancer drug when fully developed.”
National Academy of Science, 1995
CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.
There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.